Table 2 First line treatment of the patients with T/NK cell lymphoma
Number of patients n (%) | Stage I -II n (%) | Stage IV n(%) | UNKTL n (%) | EUNKTL n (%) | |
|---|---|---|---|---|---|
First line therapy | 36 (100) | 16 (45) | 20 (55) | 29 (80) | 7 (20) |
Chemotherapy alone | 25 (69) | 8 (50) | 17 (85) | 18 (62) | 7 (100) |
Chemotherapy + radiotherapy | 10 (28) | 8 (50) | 2 (10) | 10 (35) | 0 |
Radiotherapy alone | 1 (3) | 0 | 1 (5) | 1 (3) | 0 |
Anthracycline-based regimen | 26 (74) | 11 (69) | 15 (79) | 20 (71) | 6 (86) |
High-dose methotrexate + high-dose aracytine regimen | 4 (11) | 2 (12) | 2 (11) | 3 (11) | 1 (14) |
High-dose methotrexate + L-asparaginase | 2 (6) | 1 (7) | 1 (5) | 2 (7) | 0 |
Cisplatin-based regimen | 3 (9) | 2 (12) | 1 (5) | 3 (11) | 0 |